As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.
24 Analysts have issued a QIAGEN NV forecast:
24 Analysts have issued a QIAGEN NV forecast:
Jun '25 |
+/-
%
|
||
Revenue | 2,040 2,040 |
5%
5%
|
|
Gross Profit | 1,300 1,300 |
6%
6%
|
|
EBITDA | 546 546 |
19%
19%
|
EBIT (Operating Income) EBIT | 539 539 |
20%
20%
|
Net Profit | 373 373 |
414%
414%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.
Head office | Netherlands |
CEO | Thierry Bernard |
Employees | 5,232 |
Founded | 1996 |
Website | www.qiagen.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.